Select Page

Tempus, Northwestern collaboration to use AI for Alzheimer’s research

Tempus, Northwestern collaboration to use AI for Alzheimer’s research

Tempus will partner with Northwestern University’s Abrams Research Center on Neurogenomics on ways to use artificial intelligence to enhance research on Alzheimer’s Disease.

Tempus said they will use their AI data analytics platform to analyze and restructure the center’s repository of genomic data.

The goal, they said, is to uncover patterns that can improve understanding of the disease, investigate the gene and cell types affected and aid in the development of new therapeutics and novel clinical applications.

“This collaboration with Tempus represents an important step forward in our mission to harness cutting-edge technologies to transform Alzheimer’s research,” David Gate, head of The Abrams Research Center on Neurogenomics, said in a statement. “We share a commitment to deepen our understanding of the genomic underpinnings of Alzheimer’s disease and accelerate the development of more targeted, effective interventions.”

About The Author

Advertise With Us

 
health-news-illinois-advertisers-01